Valiant Laboratories IPO

Analysts’ key concern is that the company is a single-product manufacturer. “There are some concerns as it is a single-product manufacturing company. Secondly, it is dependent on a limited number of suppliers as well as customers. Also, there is intense competition in this industry. Investors might get a good listing benefit, but they should also be cautious about related risks,” said Shivani Nyati, Head of Wealth, Swastika Investmart Ltd.